Intalere welcomes Brian Williamson, Pharm.D., President and Chief Executive Officer, JCB Laboratories. Dr. Williamson devotes his time and energy to compounding and supplying sterile products to ambulatory surgery centers and hospitals and working with consultant pharmacists from around the country to help them keep their clients compliant with sterile regulations. In this session Dr. Williamson will address the drug shortage issue and why it has become a common problem for hospital pharmacies. He will review the drugs which are the most problematic for hospital pharmacies to acquire at this time. Dr. Williamson will discuss the unavailability of chemotherapeutic drugs and the evolution of the Gray Market. The term pedigree drug is defined. In conclusion, Dr. Williamson will offer recommendations on managing drug shortage issues.